Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.
about
The spectrum of disease in chronic traumatic encephalopathy11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Plasma and CSF Abeta for the longitudinal prediction of Alzheimer's disease dementia and other dementias in people with cognitive decline but no dementiaPopulation-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic reviewExisting Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluationSystematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble saltsDNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia.Biomarkers in the diagnosis of Alzheimer's disease: are we ready?Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years.Neuropathology-based risk scoring for dementia diagnosis in the elderly.In Vivo Detection of Gray Matter Neuropathology in the 3xTg Mouse Model of Alzheimer's Disease with Diffusion Tensor Imaging.Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.Dementia with Lewy bodies: basis of cingulate island sign.Lithium treatment of APPSwDI/NOS2-/- mice leads to reduced hyperphosphorylated tau, increased amyloid deposition and altered inflammatory phenotype.Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.[¹²⁵I]SD-7015 reveals fine modalities of CB₁ cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer's diseaseStaging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.The pathogenesis of Alzheimer's disease: a reevaluation of the "amyloid cascade hypothesis"Nodular bilateral amygdala degeneration in demented individuals.Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.Pattern separation and pattern completion in Alzheimer's disease: evidence of rapid forgetting in amnestic mild cognitive impairment.Non-linear relationships of cerebrospinal fluid biomarker levels with cognitive function: an observational study.Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortexMMSE scores decline at a greater rate in frontotemporal degeneration than in ADClinicopathological concordance of dementia diagnoses by community versus tertiary care clinicians.Hippocampal endosomal, lysosomal, and autophagic dysregulation in mild cognitive impairment: correlation with aβ and tau pathologyActivation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence.Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer's disease brains and human microgliaNeuroinflammation in the aging down syndrome brain; lessons from Alzheimer's disease.Understanding dementia prevalence among centenarians.Alzheimer's disease and the amyloid cascade hypothesis: a critical review.The neuropathology of chronic traumatic encephalopathy.Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.Children of persons with Alzheimer disease: what does the future hold?Mechanisms of AD neurodegeneration may be independent of Aβ and its derivatives.Intranasal Delivery of NEMO-Binding Domain Peptide Prevents Memory Loss in a Mouse Model of Alzheimer's Disease.Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies.Assessing clinicopathological correlation in chronic traumatic encephalopathy: rationale and methods for the UNITE study.
P2860
Q22242925-BEEB7DA7-3254-45C7-96A3-359FA4886DFBQ24194742-B7E21A23-EF26-4A2C-92A8-6D304F4C9F66Q24200257-0D59FA72-E0B4-4E9A-96E7-0B2A9E6EF074Q24201039-A2FE4152-42F9-4B84-99B6-0C9093BC3562Q24235058-FE8651A6-0A10-417B-84D3-34727C96E74FQ25257388-D9D4BBFB-F821-452E-A66E-C3DA8E251B1DQ27303745-FFD9D0AF-FBFA-429A-A5C6-CA47168BDC8CQ28387541-5ADBC684-D7B3-43F7-AB15-933FB236AB63Q30480102-6D69A366-1A0E-49D8-A83B-5D71907A16E3Q31050728-86CFAB27-8316-40BD-B595-D499C9D3866DQ33600226-0EDA8FD0-9656-47D4-92D3-BDFB283D29FDQ33780675-06954E49-ED78-40E9-995A-C5FF1D5930E0Q33787887-66C11D81-8983-4A57-885D-5EE1433C29E7Q34114062-6460EB89-40DD-4ADB-9B20-DCE969B0B31FQ34135742-45B9FFAC-88D8-4F5F-A951-ED6A7F1E9177Q34162967-E0835F35-708F-43D1-B5B5-8BED81017554Q34262758-BEA7120D-576F-4F91-8FC1-0142D184F406Q34269852-233CB4E5-28B7-4339-BFCE-FC00563BB6D2Q34556945-6D4F288A-8653-4B88-94AB-AB90D7F30761Q34572079-8FF4FB47-8409-4123-A7F2-C88A34CABAE1Q34669762-3FCEF7DA-9DDC-405A-937B-AE01AEA0441CQ34714560-F307A0AD-59C9-48C2-BA60-336F4F7F59FAQ35026669-148D7E00-D5F3-4629-BB11-12505307439AQ35029099-A52E0658-4F13-47EE-8F2A-A6F70C076322Q35044486-9886E8CD-027E-4847-ADC7-32706E187A1FQ35069613-7127D7FE-8053-4647-B4D5-E7256CE90569Q35113689-B13FA203-C928-435D-A9F0-5EF0C49B9FF0Q35196299-0B65FABC-A157-4FAD-AECE-703A3151BD5EQ35240865-5A4E5BCA-65F0-463A-A180-D63DAAF75A18Q35272389-77ACF0C6-3E65-49D7-9545-13F0B62044B3Q35791628-FB0D922F-3AAA-43BB-BD0E-31045FABEF1EQ35845305-7372543F-51CB-4120-9518-CDAB28EA04FEQ35855587-3D426959-3C9D-48C8-8480-F68ECE6EB6FBQ35920165-4F1057F4-A43C-4DF5-91DB-DA6917D7A25AQ35974488-E462BA7D-6174-441C-B56A-2F51CDC32384Q36039851-AAC4AE27-0F74-4962-BC4B-E0352D2CB65EQ36064687-E0262814-E026-4C3E-A442-902202B189ACQ36092100-5DA9FA6F-1FB6-4BFB-89B1-8A0BC2757164Q36146930-4D2202F7-1194-47A7-9B4F-1FBC903F7AECQ36146970-1A4A4923-17A5-463A-8624-27A5939111ED
P2860
Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Application of the National In ...... iagnosis of Alzheimer disease.
@en
Application of the National Institute on Aging
@nl
type
label
Application of the National In ...... iagnosis of Alzheimer disease.
@en
Application of the National Institute on Aging
@nl
prefLabel
Application of the National In ...... iagnosis of Alzheimer disease.
@en
Application of the National Institute on Aging
@nl
P2093
P1476
Application of the National In ...... iagnosis of Alzheimer disease.
@en
P2093
Growdon JH
Hedley-Whyte ET
P304
P356
10.1097/00005072-199911000-00004
P577
1999-11-01T00:00:00Z